purpos
evalu
effect
proteasom
inhibitor
cancer
cachexia
delin
molecular
mechan
underli
method
establish
experiment
cancer
cachexia
model
subcutan
implant
colon
cell
armpit
balbc
mice
follow
administr
variou
time
point
bodi
weight
food
intak
gastrocnemiu
muscl
weight
spontan
activ
surviv
tumorbear
mice
examin
along
tumor
growth
moreov
cachect
marker
includ
glucos
triglycerid
albumin
total
protein
well
level
proinflammatori
cytokin
tnfa
serum
gastrocnemiu
tissu
measur
final
mrna
protein
level
ijba
ubiquitin
ligas
mafbx
gastrocnemiu
muscl
assess
result
treatment
significantli
allevi
cancer
cachexia
demonstr
attenu
weight
loss
alter
carbohydr
metabol
muscl
atrophi
increas
spontan
activ
surviv
time
tumorbear
mice
reduc
tumor
growth
level
tnfa
serum
gastrocnemiu
tissu
nfjb
mafbx
also
inhibit
unexpectedli
effici
administr
earli
stage
cachexia
effect
food
intak
tumorbear
mice
conclus
result
demonstr
inhibit
ubiquitinproteasom
pathway
cancer
cachexia
decreas
activ
nfjb
degrad
ijba
reduc
level
tnfa
serum
gastrocnemiu
tissu
accompani
downregul
mafbx
data
suggest
potenti
therapeut
prevent
agent
cancer
cachexia
cancer
cachexia
affect
patient
advanc
tumor
brain
pancrea
lung
stomach
account
cancerrel
death
tisdal
fearon
multifactori
syndrom
character
progress
deplet
skelet
muscl
often
alway
accompani
loss
bodi
fat
fearon
et
al
cachexiainduc
muscl
wast
weight
loss
detriment
effect
patient
qualiti
life
major
factor
contribut
death
fearon
howev
therapeut
option
avail
cancer
cachexia
convent
nutrit
support
fulli
revers
cachect
manifest
fearon
et
al
thu
import
elucid
underli
molecular
mechan
develop
novel
treatment
strategi
improv
current
therapeut
cancer
cachexia
elev
level
proinflammatori
cytokin
includ
tumor
necrosi
factora
tnfa
contribut
pathogenesi
cancer
cachexia
mediat
system
inflamm
turn
promot
degrad
muscl
protein
saini
et
al
respons
proinflammatori
cytokin
nfjb
transcript
factor
regul
express
number
proinflammatori
marker
cytokin
chemokin
activ
thu
establish
posit
feedback
loop
result
overstimul
nfjb
fibrosi
degrad
specif
muscl
protein
kumar
et
al
li
et
al
muscl
protein
degrad
mediat
lysosom
system
cytosol
proteas
ubiquitinproteasom
pathway
among
mechan
ubiquitinproteasom
pathway
play
predomin
role
account
major
skelet
muscl
degrad
cancer
cachexia
melstrom
et
al
key
enzym
ubiquitinproteasom
system
ubiquitin
ligas
two
ligas
mafbx
muscl
ring
finger
protein
involv
skelet
muscl
atrophi
gome
et
al
bodin
et
al
accumul
data
demonstr
mafbx
regul
nfjb
judg
et
al
cai
et
al
adam
et
al
regard
regulatori
role
nfjb
ubiquitinproteasom
pathway
muscl
atrophi
intrigu
hypothes
proteasom
inhibitor
could
attenu
cancer
cachexia
specif
potent
revers
proteasom
inhibitor
block
degrad
ubiquitinconjug
ijb
therebi
inhibit
nfjb
activ
inou
et
al
recent
shown
could
reduc
immobilizationdisuseinduc
skelet
muscl
atrophi
via
inhibit
nfjb
caron
et
al
jamart
et
al
present
studi
evalu
potenti
effect
cancer
cachexia
found
amelior
cancer
cachexia
attenu
activ
nfjb
pathway
rabbit
polyclon
antibodi
ijba
subunit
nfjb
obtain
proteintech
il
usa
antimafbx
bactin
antibodi
purchas
santa
cruz
biotechnolog
ca
usa
proteas
inhibitor
dissolv
dmso
mgml
dilut
final
concentr
mgkg
prior
inject
et
al
male
balbc
mice
week
old
g
obtain
experiment
anim
center
chongq
univers
medic
scienc
china
anim
experiment
procedur
review
approv
institut
anim
care
use
committe
chongq
univers
medic
scienc
anim
hous
temperaturecontrol
room
light
dark
cycl
provid
food
water
ad
libitum
day
acclim
local
condit
induc
cancer
cachexia
mice
total
mice
inject
subcutan
murin
colon
adenocarcinoma
cell
gift
depart
patholog
chongq
univers
medic
scienc
detail
logarithm
grow
cell
harvest
use
trypsin
suspend
pb
densiti
cellsml
one
hundr
microlit
cell
suspens
inject
subcutan
armpit
mous
day
sixteen
anim
receiv
inject
pb
alon
serv
healthi
control
hc
cancer
cachexia
character
progress
weight
loss
deplet
bodi
fat
anorexia
asthenia
wast
fatigu
impair
immun
function
agustsson
et
al
faber
et
al
record
spontan
physic
activ
condit
fur
bodi
weight
anim
daili
basi
addit
tumor
growth
monitor
tumor
volum
determin
use
follow
formula
tumor
volum
v
mm
b
repres
length
millimet
b
width
millimet
tumorbear
mice
subsequ
treat
pb
variou
time
point
random
three
group
mice
group
prevent
group
mp
treat
day
zhou
et
al
tumor
palpabl
treatment
group
mt
inject
intraperiton
day
advanc
cachexia
symptom
observ
cancer
cachexia
group
cc
inject
steril
pb
similar
condit
day
blood
sampl
retroorbit
plexu
perform
mice
group
serum
obtain
clot
blood
room
temperatur
h
follow
centrifug
rpmmin
min
frozen
prior
analys
thereaft
mice
kill
via
cervic
disloc
tumor
gastrocnemiu
muscl
left
leg
dissect
weigh
muscl
specimen
snapfrozen
fix
buffer
formalin
histochemistri
studi
remain
mice
mice
group
spontan
physic
activ
food
intak
surviv
time
record
analyz
gastrocnemiu
muscl
embed
paraffin
section
serial
slice
stain
hematoxylin
eosin
h
e
imag
acquir
use
invert
light
microscop
magnif
analyz
imag
j
softwar
http
rsbinfonih
govij
approxim
muscl
fiber
muscl
analyz
crosssect
area
quantif
serum
glucos
triglycerid
total
protein
albumin
measur
use
autom
biochemistri
analyz
tnfa
level
serum
gastrocnemiu
muscl
determin
use
sandwich
elisa
accord
manufactur
protocol
total
rna
isol
gastrocnemiu
muscl
use
trizol
reagent
takara
china
reversetranscrib
cdna
accord
manufactur
instruct
realtim
pcr
perform
use
sybr
green
quantit
revers
transcript
pcr
system
kapa
biosystem
usa
realtim
pcr
contain
dilut
cdna
primer
kapa
sybr
fast
qpcr
master
mix
ddh
primer
use
summar
tabl
realtim
pcr
perform
use
abi
prism
sequenc
detect
system
appli
biosystem
follow
reaction
condit
min
follow
cycl
threestep
reaction
denatur
anneal
extens
melt
curv
analys
perform
biorad
cfx
manag
biorad
ensur
amplif
specif
transcript
level
target
gene
normal
gapdh
rel
fold
chang
express
calcul
use
compar
ct
method
nuclear
total
protein
extract
gastrocnemiu
muscl
tumor
tissu
quantifi
use
bca
assay
protein
lysat
subsequ
resolv
use
sdspage
transfer
onto
polyvinyliden
difluorid
membran
beyotim
institut
biotechnolog
china
follow
block
skim
milk
h
membran
incub
specif
primari
antibodi
overnight
thereaft
membran
wash
tbst
incub
secondari
goat
antirabbit
igghrp
horseradish
peroxidas
conjug
h
room
temperatur
protein
band
interest
visual
follow
final
wash
tbst
develop
film
analyz
use
gel
imag
system
softwar
statist
analys
perform
use
spss
data
express
mean
standard
deviat
x
oneway
anova
perform
two
anim
group
compar
wherea
snkq
analys
employ
pairwis
comparison
surviv
analyz
use
logrank
test
p
consid
statist
signific
tumorbear
mice
underw
lethal
wast
demonstr
progress
weight
loss
tumor
growth
tanaka
et
al
evalu
effect
administ
tumorbear
mice
variou
stage
cachexia
analyz
chang
bodi
weight
although
appar
differ
day
postimplant
term
bodi
weight
signific
differ
note
mice
mp
cc
group
mp
mt
group
start
day
p
day
signific
weight
loss
observ
mice
cc
mp
mt
group
p
moreov
drastic
differ
term
carcass
weight
excis
tumor
burden
note
mp
cc
group
p
interestingli
slight
signific
differ
bodi
weight
observ
two
group
bodi
weight
tumor
weight
volum
also
record
tumorbear
mice
shown
fig
sequenc
cc
mice
respect
administr
advanc
cachexia
day
less
effect
allevi
weight
loss
inhibit
tumor
growth
p
bodi
weight
mice
mt
group
remain
heavier
cc
mice
addit
tumor
volum
weight
mt
group
cc
mice
respect
fig
besid
weight
loss
anorexia
anoth
characterist
symptom
cancer
cachexia
consist
previou
studi
signific
differ
food
intak
observ
group
tanaka
et
al
data
shown
result
demonstr
amelior
weight
loss
inhibit
tumor
growth
tumorbear
mice
revers
skelet
muscl
atrophi
increas
spontan
physic
activ
prolong
life
span
tumorbear
mice
cancer
cachexia
mark
decreas
skelet
muscl
mass
hind
limb
observ
tumorbear
cc
mice
fig
left
moreov
gastrocnemiu
muscl
weight
fig
right
crosssect
area
fig
cc
mice
hc
mice
respect
contrast
gastrocnemiu
muscl
weight
mp
mt
mice
higher
cc
mice
respect
histolog
analys
demonstr
rescu
least
partial
gastrocnemiu
muscl
atrophi
gastrocnemiu
crosssect
area
mp
mt
mice
larger
cc
mice
fig
moreov
treatment
led
increas
spontan
physic
activ
prolong
surviv
tumorbear
mice
compar
hc
mice
cc
mice
exhibit
signific
reduct
spontan
physic
activ
total
distanc
hc
fig
respons
treatment
signific
increas
spontan
physic
activ
observ
mp
mt
group
furthermor
treatment
begin
day
effect
restor
spontan
physic
activ
tumorbear
mice
fig
next
record
surviv
time
tumorbear
mice
plot
kaplanmei
surviv
curv
surviv
time
mice
mp
mt
group
day
longer
cc
mice
respect
howev
seem
surviv
time
correl
time
first
dose
cours
cachexia
fig
thu
could
revers
skelet
muscl
atrophi
increas
spontan
physic
activ
prolong
life
span
tumorbear
mice
particularli
earli
stage
cancer
cachexia
despit
reduc
calori
intak
signific
higher
rate
glucos
triglyceridefatti
acid
cycl
c
spontan
activ
measur
infrar
monitor
system
tokyo
japan
kaplanmei
surviv
curv
plot
base
data
remain
mice
group
column
bar
repres
mean
three
independ
experi
x
standard
deviat
p
compar
hc
mice
p
p
compar
cc
mice
p
p
compar
mp
mt
mice
gluconeogenesi
observ
patient
cachexia
holroyd
et
al
examin
effect
alter
metabol
pathway
cachect
mice
measur
glucos
triglycerid
albumin
total
protein
level
serum
shown
fig
cc
mice
show
significantli
reduc
level
glucos
albumin
total
protein
compar
hc
mice
interestingli
elev
level
triglycerid
observ
cc
mice
fig
administr
restor
serum
glucos
albumin
total
protein
level
reduc
triglycerid
level
addit
administr
earli
stage
cachexia
effect
restor
carbohydr
metabol
fig
ad
data
suggest
effici
restor
defect
carbohydr
metabol
tumorbear
mice
well
document
number
proinflammatori
cytokin
includ
tnfa
interferon
c
play
critic
role
develop
cancer
cachexia
argil
lopezsoriano
examin
whether
exert
anticachexia
function
attenu
express
secret
proinflammatori
cytokin
perform
elisa
measur
tnfa
level
serum
gastrocnemiu
muscl
tumorbear
mice
shown
fig
tnfa
level
serum
gastrocnemiu
tissu
significantli
higher
cc
mice
compar
hc
mice
serum
level
tnfa
mt
mp
mice
lower
cc
mice
respect
similarli
level
serum
mt
mp
mice
lower
cc
mice
respect
fig
gastrocnemiu
muscl
mp
mt
mice
tnfa
level
also
significantli
reduc
effect
promin
administ
earli
stage
cachexia
fig
therefor
suppress
upregul
tnfa
serum
gastrocnemiu
muscl
tumorbear
mice
data
demonstr
elev
proinflammatori
cytokin
level
accompani
progress
cancer
cachexia
express
cytokin
regul
nfjb
turn
cytokin
serv
potent
activ
nfjb
whose
activ
play
critic
role
skelet
muscl
atrophi
li
et
al
guttridg
et
al
ubiquitinproteasom
pathway
involv
degrad
regulatori
structur
muscl
protein
blood
sampl
perform
day
kill
serum
level
glucos
triglycerid
b
albumin
c
total
protein
measur
data
repres
mean
sd
x
p
p
compar
hc
mice
p
p
compar
cc
mice
p
compar
mp
mt
mice
myofibrillar
protein
increas
activ
nfjb
lead
skelet
muscl
atrophi
enhanc
ubiquitinproteasom
proteolyt
pathway
cai
et
al
cao
et
al
recent
data
show
reduc
skelet
muscl
atrophi
inhibit
nfjb
activ
caron
et
al
jamart
et
al
data
led
us
hypothes
amelior
cachexia
prevent
skelet
muscl
atrophi
regul
nfjbmediat
ubiquitinproteasom
proteolysi
examin
express
ijba
mafbx
gastrocnemiu
muscl
tumorbear
mice
use
realtim
pcr
western
immunoblot
dramat
reduct
mrna
ijba
observ
cc
mice
compar
hc
group
fig
mrna
level
mafbx
significantli
increas
tumorbear
cc
mice
fig
elev
mrna
ijba
time
attenu
mrna
level
mafbx
moreov
effect
evid
mice
receiv
first
dose
earli
cours
cachexia
fig
similar
protein
pattern
also
observ
fig
result
demonstr
inhibit
nfjbmediat
ubiquitinproteasom
proteolysi
cachect
anim
particularli
earli
stage
cancer
cachexia
examin
whether
anticanc
effect
also
involv
nfjbmediat
ubiquitinproteasom
proteolysi
examin
ijba
level
use
immunoblot
found
nfjb
signal
inhibit
fig
howev
express
mafbx
affect
treatment
data
shown
highli
debilit
characterist
mani
cancer
cachexia
complic
cancer
treatment
diminish
qualiti
life
reduc
life
span
patient
advanc
malign
dodson
et
al
though
number
pharmacotherapeut
agent
variou
mechan
action
current
evalu
current
drug
approv
prevent
treatment
cancer
cachexia
regard
critic
role
muscl
atrophi
target
nfjb
pathway
promis
strategi
studi
curcumin
demonstr
inhibit
nfjb
signal
result
muscl
regener
mice
thaloor
et
al
direct
target
nfjb
dna
bind
site
intratumor
inject
oligonucleotid
inhibit
cachexia
mous
model
kawamura
et
al
fig
treatment
reduc
elev
level
tnfa
tumorbear
mice
tnfa
b
level
serum
evalu
elisa
c
tnfa
level
gastrocnemiu
muscl
measur
use
elisa
data
repres
mean
standard
deviat
x
p
p
compar
hc
mice
p
p
compar
cc
mice
p
p
compar
mp
mt
mice
moreov
princip
polyphenol
compon
green
tea
shown
regul
nfjb
attenu
skelet
muscl
atrophi
cancer
cachexia
wang
et
al
known
proteasom
inhibitor
could
block
activ
nfjb
stabil
phosphoryl
ijba
therefor
specul
proteasom
inhibitor
might
amelior
cancer
cachexia
inhibit
nfjb
pathway
test
hypothesi
establish
cancer
cachexia
mous
model
treat
proteasom
inhibitor
variou
time
point
cachexia
found
could
effect
revers
skelet
muscl
atrophi
inhibit
tumor
growth
accompani
downregul
nfjbubiquitinproteasom
pathway
potent
revers
proteasom
inhibitor
whose
clinic
implic
studi
extens
instanc
togeth
immunosuppress
celastrol
improv
sialidosi
oleari
igdoura
sever
acut
respiratori
syndrom
sar
effect
inhibit
replic
sar
coronaviru
schneider
et
al
moreov
shown
allevi
liver
injuri
induc
intestin
ischemia
rat
jing
et
al
abl
suppress
cytomegalovirusspecif
immun
respons
wang
et
al
recent
therapeut
potenti
cancer
treatment
evalu
regardless
cancer
type
promis
anticanc
agent
function
inhibit
tumor
cell
growth
induc
cancer
cell
apoptosi
guo
sung
et
al
zanottofilho
et
al
lombardo
et
al
present
studi
show
skelet
muscl
atrophi
induc
cachexia
significantli
revers
treatment
result
consist
previou
studi
show
prevent
muscl
dystrophi
winder
et
al
disuseinduc
atrophi
caron
et
al
immobilizationmedi
skelet
muscl
atrophi
jamart
et
al
amelior
skelet
muscl
atrophi
reduc
tumor
burden
treatment
led
reduc
weight
loss
improv
spontan
activ
longer
surviv
time
tumorbear
mice
suggest
potenti
therapeut
agent
cancer
cachexia
treatment
moreov
administr
earli
stage
cancer
cachexia
effect
allevi
cachect
manifest
support
observ
prevent
intervent
manag
cancer
cachexia
import
fearon
et
al
previou
studi
indic
proinflammatori
cytokin
includ
tnfa
play
critic
role
c
mafbx
gastrocnemiu
muscl
determin
use
realtim
pcr
data
repres
mean
sd
x
p
p
compar
hc
mice
p
p
compar
cc
mice
p
compar
mp
mt
mice
regul
muscl
mass
protein
degrad
cachexia
carson
baltgalvi
pajak
et
al
observ
current
studi
elev
serum
gastrocnemiu
muscl
level
tnfa
correl
enhanc
muscl
wast
weight
loss
cachexia
wherea
administr
led
signific
reduct
tnfa
serum
gastrocnemiu
muscl
accompani
allevi
cancer
cachexia
manifest
previou
studi
demonstr
could
reduc
pain
inflamm
inhibit
nfjb
signal
ahm
et
al
data
indic
anticachexia
effect
also
mediat
suppress
nfjb
pathway
elev
express
ijba
reduc
level
gastrocnemiu
muscl
observ
mice
receiv
treatment
agreement
previou
studi
show
inhibit
express
mafbx
could
revers
skelet
muscl
atrophi
muscl
protein
degrad
glass
show
significantli
reduc
mafbx
moreov
western
immunoblot
protein
extract
tumor
tissu
reveal
could
imped
tumor
growth
target
nfjb
pathway
like
observ
zanottofilho
et
al
studi
zanottofilho
et
al
howev
ubiquitinproteasom
pathway
seem
contribut
anticanc
effect
express
mafbx
affect
therefor
may
attenu
cancer
cachexia
block
activ
nfjb
henc
upregul
tnfa
inhibit
downstream
ubiquitinproteasom
pathway
western
immunoblot
analys
perform
detect
effect
protein
level
ijba
b
c
mafbx
gastrocnemiu
muscl
upper
panel
repres
immunoblot
lower
panel
indic
quantif
protein
band
intens
use
gel
imag
system
softwar
protein
data
repres
mean
sd
x
p
p
compar
hc
mice
p
p
compar
cc
mice
p
p
compar
mp
mt
mice
mafbx
therebi
amelior
muscl
atrophi
muscl
protein
degrad
summari
treatment
could
effect
allevi
cancer
cachexia
prevent
weight
loss
muscl
atrophi
increas
spontan
activ
surviv
time
moreov
anticachexia
effect
potenti
interact
regul
nfjb
downstream
ubiquitinproteasom
pathway
given
high
efficaci
particularli
administr
earli
stage
cancer
cachexia
data
also
indic
might
use
prevent
measur
cancer
cachexia
data
repres
mean
sd
x
p
p
compar
hc
mice
p
p
compar
cc
mice
p
p
compar
mp
mt
mice
